| IOVA |    | Iovance Biotherapeutics, Inc. - Common Stock | | | -2.44% -2.44% 0 | | + Biotechnology, Gene and cell, Immunology, Cancer fight, Disease: Oncology, T cell-based
Last highlighted: 8-K Sec report https://www.sec.gov/Archives/edgar/data/1425205/000110465924075997/0001104659-24-075997-index.htm
8-K - IOVANCE BIOTHERAPEUTICS, INC. (0001425205) (Filer) | + My List |
| CNTB | | Connect Biopharma Holdings Limited - American Depositary Shares | | | 2.21% 2.21% 0 | | + Biopharma, Country: China, T cell-based
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1835268/000183526824000017/0001835268-24-000017-index.htm
6-K - Connect Biopharma Holdings Ltd (0001835268) (Filer) | + My List |
| LVTX | | LAVA Therapeutics N.V. - Ordinary Shares | | | -1.9% -1.9% 0 | | + T cell-based, Cancer fight, Medicine, Disease: Oncology
Last highlighted: 6-K Sec report https://www.sec.gov/Archives/edgar/data/1840748/000155837024009357/0001558370-24-009357-index.htm
6-K - LAVA Therapeutics NV (0001840748) (Filer) | + My List |
| BTMD | | Biote Corp. - Class A common stock | | | 1.52% 1.52% 0 | | + T cell-based, Biotechnology, Immunology, Medicine
| + My List |
